Rare diseases
Investigational molecules
Locations
800 Ridgeview Drive, 19044-3607, United States
Research activity is centered on castration-resistant prostate cancer, with a focus on disease control in men whose cancer no longer responds to androgen deprivation. The clinical interest extends to non-metastatic castration-resistant prostate cancer and the prevention of spread to distant sites.
The sponsor’s work in this area reflects a therapeutic emphasis on delaying metastatic progression in advanced prostate cancer and supporting treatment options for men with high-risk disease.
Aragon Pharmaceuticals Inc. runs clinical trials in conditions such as Prostate cancer metastatic, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
